Search results for “Slow-reacting substance of anaphylaxis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 180 patents, we discovered top 25 key players by total patent application. Merck Frosst Canada & Co., Yamanouchi Pharmaceutical Co., Ltd., Fisons Ltd. are dominant in this area. They take 47.22% of the total patent filing.
Merck Frosst Canada & Co.
Canada
Patent: 49
Yamanouchi Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 18
Fisons Ltd.
BERKSHIRE, United Kingdom
Patent: 18
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 12
Tokyo Tanabe Co. Ltd.
Tokyo-to, Japan
Patent: 12
Pfizer Inc.
New York, United States
Patent: 8
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 7
Schering Corp.
New Jersey, United States
Patent: 7
ICI Americas, Inc.
Delaware, United States
Patent: 6
Fujisawa Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: